Rationale: Intimal calcification is highly correlated with atherosclerotic plaque burden, but the underlying mechanism is poorly understood. We recently reported that cartilage oligomeric matrix protein (COMP), a component of vascular extracellular matrix, is an endogenous inhibitor of vascular smooth muscle cell calcification. 
D
uring the past 2 decades, vascular calcification has been increasingly recognized as an independent risk factor for cardiovascular mortality in humans, and there is no pharmacological therapy for this condition. [1] [2] [3] The clinical consequences of vascular calcification are largely dependent on its location and extent and on the organs affected. Medial calcification is commonly associated with aging, type II diabetes mellitus, and end-stage renal disease, 4 whereas intimal calcification is highly correlated with atherosclerotic plaque burden. 5 Compelling evidence has indicated that coronary artery calcification is strongly associated with a high risk of cardiovascular events, independently of traditional risk factors. A recent prospective study using 18 F-sodium fluoride positron emission tomography further revealed that microcalcification is a good predictor of susceptibility to plaque rupture. 6 The cellular context of atherosclerotic calcification involves both macrophages and vascular smooth muscle cells (VSMCs). 7 An in vivo genetic fate mapping study revealed that VSMCs in atherosclerotic plaques transdifferentiate into the osteogenic phenotype in a process that mimics osteoblastic differentiation of skeletal bone cells. 8 In contrast, the role of macrophages in lesion calcification is incompletely understood. Although some in vitro coculture studies indicate that monocytes/macrophages enhance VSMC calcification by releasing proinflammatory cytokines, [9] [10] [11] [12] other studies proposed that osteogenic VSMCs promote macrophage infiltration into the calcified lesion to form osteoclast-like cells, [13] [14] [15] and differentiation of macrophages into osteoclast-like cells may cause the demineralization of elastin-oriented vascular calcification and therefore inhibit the process. 16, 17 Further studies using macrophage-specific knockout mice have indicated the importance of the macrophage-derived osteoprotegerin/receptor activator of nuclear factor-κB ligand/receptor activator of nuclear factor-κB triad, 18 glucocorticoid receptor, 19 and matrix vesicles 20 in regulating lesion calcification. Nevertheless, it is still unclear how macrophages affect atherosclerotic calcification and what mediators are involved.
Cartilage oligomeric matrix protein (COMP), a 524-kDa pentameric noncollagenous glycoprotein, is a matricellular protein found in both the musculoskeletal and cardiovascular systems. Our recent studies have shown that COMP plays critical roles in maintaining homeostasis in the cardiovascular system. COMP maintains the contractile phenotype of VSMCs via integrin α7 and prevents osteochondrogenic transdifferentiation of VSMCs by binding directly to bone morphogenetic protein 2, thereby inhibiting VSMCs or medial calcification. 21, 22 ADAMTS-7 (a distintegrin and metalloproteinase with thrombospondin motifs), the only COMP-degrading enzyme identified in blood vessels, increases atherosclerotic neointima formation and VSMC calcification. 23, 24 Intriguingly, ADAMTS-7 has been shown through genome-wide association studies to be connected with coronary artery heart disease and coronary/aortic calcification in humans. [25] [26] [27] Considering the difference between intimal and medial calcification, it is still not clear whether COMP is also involved in atherosclerotic calcification. Here, we show that COMP deficiency switched the macrophage phenotype and contributed directly to atherosclerotic lesion calcification. Mechanistically, COMP regulated the macrophage phenotype via integrin β3.
Methods

Animals
All animal studies followed the guidelines of the Animal Care and Use Committee of Peking University. COMP −/− mice in the C57BL/6 background strain were kindly provided by Professor Ake Oldberg from the Department of Cell and Molecular Biology at Lund University, Sweden. 28 
Analysis of Atherosclerotic Plaques and Calcification
For morphometric analysis of lesions, cross sections of various artery parts, including aortic root, aortic arch, and innominate artery, were prepared individually. Moving up from the base of heart, aortic root region begins at the first appearance of the valve cups dividing the lumen into 3 distinct regions and ends when the valve cups no longer divide the lumen and the wall seems more rounded and distinct. Aortic arch region for lesion analysis starts at the branch point of innominate artery and then moves backward to the aortic root. Innominate artery region begins at its origin on the outer curve of aortic arch and ends at its first branch, which is divided as right common carotid artery and right subclavian artery. Every 3 continuous 7-μm-thick sections were made on separate slides without interval for aortic root and with 70-μm intervals for aortic arch and innominate artery, respectively, with a cryostat through these arterial parts. For each mouse, 3 sets of 10 interval sections were applied for Oil Red O, von Kossa, and Movat pentachrome stainings. Staining data (in %) for each mouse were presented as the mean of 10 sections.
Real-Time Polymerase Chain Reaction
SYBR Green 2× polymerase chain reaction mix (TransGen Biotech, Beijing, China) was used according to the manufacturer's instructions. Primers used in the present study are listed in Online Table I .
Statistical Analysis
Values are expressed as mean±SEM. Treatment group values were compared with their controls using GraphPad Prism 6.0 (GraphPad Software, San Diego, CA). In all cases, statistical significance was included where the 2-tailed probability was <0.05. More detailed Methods are available in the Online Data Supplement.
Results
ApoE −/−
COMP −/− Mice Fed With Chow Diet Develop Cartilaginous Metaplasia and Atherosclerotic Calcification
To investigate the role of COMP in atherosclerotic calcification, we first compared lesion formation and development between 12-month-old ApoE −/− and ApoE −/− COMP −/− male mice fed with normal chow diet. There were no differences in body weight, blood pressure, blood cell profile, serum lipids, or biochemical indexes between these 2 genotypes (Online Table II ). However, aortic en face Oil Red O staining showed that ApoE −/− COMP −/− mice developed more extensive atherosclerotic lesions than ApoE −/− mice (Online Figure IA) . Furthermore, we analyzed atherosclerotic plaques in the following artery locations: aortic root, aortic arch, and innominate artery. Oil Red O staining showed that plaques in all 3 locations were increased markedly in ApoE 
COMP
−/− mice in innominate artery. 29 As shown in Movat staining in Figure 1A , cartilaginous matrices consisting of a collagen-(yellow) and proteoglycan-(blue) rich extracellular matrix embedded with chondrocyte-like cells (red arrow) characterized by a relatively large amount of clear cytoplasm surrounded by a lacunar rim were found in deep intima of ApoE 
Bone Marrow-Derived COMP Is Involved in Atherosclerotic Calcification
Vascular cells and leukocytes are 2 major cellular origins of atherosclerotic lesions and calcification. Therefore, we profiled the expression of COMP and found that COMP expression was high in VSMCs, low in fibroblasts, and undetectable in endothelial cells (Online Figure IIIA) . Among unstimulated leukocytes, COMP was mainly detected in macrophages and not in lymphocytes (Online Figure IIIB) . To investigate the cell origin of COMP, we isolated bone marrow cells from ApoE −/− and ApoE −/− COMP −/− mice and injected them into lethally irradiated male mice of both genotypes, respectively. After bone marrow transplantation, chimeric mice were first genotyped to validate the success of transplantation (Online Figure IV ) and then were fed with a Western-type diet for 16 weeks to accelerate the formation of atherosclerotic calcification. 30 There were no differences among the mice fed the Western-type diet in body weight, blood pressure, blood cell profile, serum lipids, and biochemical indexes, including phosphate, calcium, blood urea nitrogen, and creatinine (Online Table III (Figure 2B and 2C) . Similar results were obtained by the use of von Kossa staining to quantify the atherosclerotic calcification in chimeric mice (Figure 2A and 2E Figure 2D ). Together, these data suggest that bone marrow cell-derived COMP played a more critical role in atherosclerotic calcification than nonbone marrow-derived COMP. Moreover, there is a synergistic effect on lesion calcification between bone marrow-derived cells and vascular cells.
To further address the cellular origin of COMP in atherosclerotic calcification, we created transgenic mice specifically expressed COMP in VSMCs (COMP-Tg) under the control of VSMC promoter SM-22 in the C57/BL6 background (Online Figure VIA) . Four independent mouse lines were generated and detected for COMP expression in aorta (Online Figure  VIB) . We chose the line 3 of mice for subsequent analysis. We further validated that COMP specifically overexpressed in aorta rather than heart, liver, and lung in COMP-Tg mice (Online Figure VIC) . First, we compared the calcium deposition of high-phosphate-treated aortic rings from wild-type (WT) and SMC COMP-Tg mice (Online Figure VID) . We found that COMP-Tg in VSMCs decreased calcium deposition of aortic rings, indicating that VSMC-derived COMP inhibited VSMC calcification coinciding with our previous data. 22 To further explore the role of VSMC-derived COMP in atherosclerotic calcification, 6-month-old ApoE −/− and SMC COMP-Tg ApoE −/− mice fed with Western-type diet for 12 weeks were applied to evaluate atherosclerotic lesions and calcification. There were no differences in body weight and serum lipids between these 2 genotypes (Online Table IV ). Interestingly, COMP-Tg in VSMCs attenuated the atherosclerotic plaques but exhibited no effect on the area of cartilaginous metaplasia, the percentage of chondrocyte-like cells, and necrotic core area in ApoE −/− mice (Online Figure VIE- Figure VIII) . Among the upregulated genes, 4 pathways related to atherosclerosis and calcification were revealed and verified, including inflammation (TLR4, interleukin 
P=8.907×10
−08 ); however, gene profile of COMP-deficient macrophages negatively correlated with that of the anti-inflammatory (M2c macrophages activated by glucocorticoids: correlation factor, −0.029; P<0.00016) and osteoclast-like phenotypes (correlation factor, −0.029; P=0.00017; Online Table V) .
To provide further functional evidence for the macrophage phenotype switch, we measured IL-6 and TNF-α in conditioned medium from peritoneal macrophages; we found that COMP deficiency elevated the secretion of these 2 proinflammatory cytokines ( Figure 4A ). In addition, the extracellular release of H 2 O 2 and the endocytosis of DiI-labeled acetylated low-density lipoprotein were both enhanced in COMP −/− peritoneal macrophages compared with WT cells (Figure 4B and 4C). These results indicated that COMP deficiency promoted a proatherosclerotic phenotype in peritoneal macrophages. Next, we tested whether conditioned medium from macrophages lacking COMP would accelerate VSMC calcification ( Figure 4D ). Indeed, even without high-phosphate treatment, calcium deposition in VSMCs was elevated by conditioned medium from COMP −/− macrophages. A further increase in calcium deposition was observed when COMP −/− VSMCs were cultured in conditioned medium from COMP −/− macrophages, suggesting that VSMCs and macrophages have a 
COMP −/− Macrophages Exhibit an Atherogenic and Osteogenic Phenotype in Atherosclerotic Lesions
To further evaluate the macrophage phenotypes in atherosclerotic lesions, we used flow cytometry to analyze single-cell suspensions digested from aortic tissue. CD45
+ and F4/80 + were 
Integrin β3 Mediates the Phenotypic Shift in Macrophages Induced by COMP Deficiency
Integrins are recognized as cell surface receptors for matrix proteins and mediate the transduction of signals across the plasma membrane. We have reported that integrin β1 binds directly to COMP, whereas α7β1 mediates the effect of COMP on the phenotype of VSMCs. 22, 31 Integrins α5β1 and αVβ3 mediate the attachment of chondrocytes to COMP. 32 Moreover, previous studies have indicated that integrin β3 deficiency macrophages aggravated atherosclerosis 33 and promoted osteosclerosis or osteopetrosis, 34 consistent with the phenotype of COMP −/− macrophages. To test whether integrin β1 or β3 mediates the role of COMP in inducing the phenotypic switch in macrophages, we first measured the levels of integrin β1 and β3 mRNA. COMP deficiency had no effect on the expression of integrin β1 or β3 mRNA (Online Figure XIA ). In contrast, the level of integrin β3 protein, but not integrin β1 protein, was decreased in COMP-deficient macrophages (Online Figure  XIB) . Decreased protein expression of integrin β3 was verified in plaque macrophages from ApoE Figure XIIA) . The overexpression of integrin β3 in macrophages after AAV2-integrin β3 infection was validated by real-time polymerase chain reaction and Western blot (Online Figure XIIB and XIIC). There were no differences in body weight and serum lipids between these 2 groups of infected mice (Online Table VI ). We analyzed atherosclerotic lesion and plaque composition by Movat pentachrome staining. Mice infected with AAV2-integrin β3 showed attenuated plaque area (Online Figure XIID) and diminished percentages of cartilaginous metaplasia, area containing chondrocyte-like cells and necrotic core area ( Figure 6B-6E ). Moreover, we evaluated the gene expression of lesional macrophages isolated from aortas via fluorescence-activated cell sorting. As shown in Figure 6F , overexpression of integrin β3 in lesional macrophages via AAV2 transfusion inhibited COMP deficiency-enhanced IL-6, p47phox, LOX-1, and Wnt10b expression. Thus, integrin β3 mediated the atherogenic and osteogenic phenotype induced in macrophages by COMP deficiency in vitro and in vivo.
As we reported previously that COMP knockdown induces VSMC dedifferentiation, 21 which also contributed to vascular calcification, we asked if integrin β3 in VSMCs mediated COMP deficiency-enhanced dedifferentiation. We measured integrin β3 in VSMCs after COMP silencing by real-time polymerase chain reaction and Western blot. There were no changes at both mRNA and protein levels (Online Figure XIIIA and XIIIB). Next, we asked whether overexpression of integrin β3 could reverse COMP silencing-induced VSMC phenotypic switching, similar to that integrin β3 blocked the effect of COMP deficiency in macrophages. However, integrin β3 overexpression seemed not affecting the decrement of VSMC contractile genes (SM-22α, α-actin, and calponin) induced by COMP silencing (Online Figure XIIIC-XIIIE) . These results indicated the COMP-integrin β3 axis in macrophages but not in VSMCs is involved in atherosclerotic calcification.
COMP Binds Directly to Integrin β3 in Macrophages
To investigate further how COMP regulates integrin β3, we first performed coimmunoprecipitation experiments in peritoneal macrophages. As shown in Figure 7A , integrin β3 was immunoprecipitated by anti-COMP antibodies but not by rabbit IgG. Notably, COMP could also be exclusively immunoprecipitated by anti-integrin β3 antibodies ( Figure 7B ). This finding implies that COMP binds to integrin β3 in macrophages. Next, a mammalian 2-hybrid assay was used to identify the domains at which COMP and integrin β3 bind. To identify the potential COMPbinding motif within integrin β3, we generated pBIND plasmids subcloning the following distinct domains of integrin β3: aa 1 to 461 (hybrid and PSI [plexin-semaphorin-integrin] domains), aa 462 to 628 (epidermal growth factor repeats), aa 629 to 717 (β-tail domain), and aa 718 to 787 (transmembrane and cytoplasmic domains). These pBIND plasmids were cotransfected with a pACT vector with full-length COMP into COS-7 cells. Only the membrane-proximal β-tail domain bound to COMP ( Figure 7C ). In addition, to identify the integrin β3-binding motif in COMP, we subcloned various domains of COMP (N terminus, EGF repeats, type III repeats, and C terminus) into pACT plasmids. The constructs were coexpressed with the β-tail domain of the integrin β3-fused pBIND plasmid into COS-7 cells. The dual luciferase reporter assay revealed that the C-terminal domain of COMP and full-length COMP bound to the integrin β3 β-tail domain ( Figure 7D ). Thus, integrin β3 was identified as a COMP-binding protein in macrophages.
Blocking Binding Between COMP and Integrin β3 Primes Macrophages to Adopt an Atherogenic and Osteogenic Phenotype
To further address whether COMP-integrin β3 binding is essential for regulating macrophage phenotype, the β-tail domain of integrin β3 was used as a dominant negative fragment and transfected into macrophages to block the binding between COMP and integrin β3 (Online Figure XIVA) . Transfection of the β-tail domain plasmid significantly reduced the protein level of integrin β3 in control macrophages, which are greatly similar to COMP −/− macrophages ( Figure 7E ). Moreover, interrupting binding between COMP and integrin β3 promoted the expression of TLR4, IL-6, iNOS, p47phox, LOX-1, and Wnt10b in WT macrophages ( Figure 7F ), mimicking the effects of COMP deficiency in macrophages. Furthermore, we transduced AAV2-GFP or AAV2-β-tail domain into 4-monthold ApoE −/− mice, respectively. The overexpression of β-tail domain in macrophages was confirmed by real-time polymerase chain reaction (Online Figure XIVB) . Coinciding with in vitro results, β-tail domain overexpression in macrophages of ApoE −/− mice decreased integrin β3 protein levels in vivo (Online Figure XIVC) . There were no differences with regard to body weight and serum lipids between these 2 genotypes (Online Table VII ). Atherosclerotic lesion and plaque composition analysis between AAV2-GFP-infected and AAV2-β-tail domain-infected ApoE −/− mice showed that overexpression of β-tail domain greatly enhanced atherosclerotic plaque (Online Figure XIVD) and markedly aggravated the percentages of cartilaginous metaplasia, area containing chondrocyte-like cells and necrotic core area ( Figure 8A-8D ). In addition, lesional macrophages with β-tail domain overexpression enhanced the expression of IL-6, iNOS, p47phox, LOX-1, and Wnt10b ( Figure 8E ). These provide supporting evidence that COMP modulates macrophage phenotypes through its interaction with integrin β3 in vitro and in vivo.
Discussion
The main finding of our study is that COMP deficiency accelerates atherosclerotic calcification in mice, which may be associated with instability of atherosclerotic plaques. Intriguingly, COMP deficiency in macrophages drove the atherogenic and osteogenic phenotypic switch of macrophages in the lesion and may subsequently contribute to atherosclerotic calcification and plaque instability. Our study reveals the importance of this macrophage phenotypic shift in atherosclerotic calcification.
The contribution of macrophages to atherosclerotic calcification remains unclear. Previously, osteoclast-like cells, differentiated from hematopoietic precursors of the mononuclear phagocyte lineage, have been proposed to be able to remove artery wall mineral deposits for cell-based therapy because osteoclasts reduced the mineral content of calcified elastin in vitro 35 and because osteoclast-like cells in calcified atherosclerotic lesions from humans and mice are decreased after atherosclerotic calcification. 36 However, with the recognition of the osteoprotegerin/receptor activator of nuclear factor-κB triad/receptor activator of nuclear factor-κB ligand triad in calcification of the atheromatous plaques, contradictory results were reported. Knockout of osteoprotegerin, the inhibitor of receptor activator of nuclear factor-κB ligand-dependent osteoclast formation, leads to reduced lesion calcification. 37, 38 Similarly, VSMC-specific knockout of Runx2 reduced the level of receptor activator of nuclear factor-κB ligand and subsequent osteoclast differentiation of macrophages and thereby inhibited atherosclerotic calcification.
14 However, all of these previous studies characterized the osteoclast-like macrophages in the lesions by using a few cell markers and not by expression profiling. Moreover, previous studies reported that proinflammatory macrophages were activated by lipid oxidation products and basic calcium phosphate crystals during atherosclerotic calcification. 11 The secretion of proinflammatory cytokines (TNF-α, IL-1, and IL-8) or matrix vesicles by activated macrophages has been suggested to be involved in atherosclerotic calcification. 11, 20 However, the subtypes of macrophages activated during lesional calcification have not been fully characterized. Here, we analyzed the mRNA profile of COMP −/− macrophages and compared it with the existing gene array data for various macrophage subtypes. Our study revealed that gene expression by COMP-deficient macrophages positively correlated with that of M1, M2b, and Mox cells (the proinflammatory/atherogenic phenotypes) but negatively correlated with that of M2c macrophages and osteoclasts (the anti-inflammatory and antiosteogenic phenotypes). Further flow cytometric measurements confirmed that the profile of COMP −/− macrophages shifted toward proinflammatory and pro-osteogenic phenotypes, which is consistent with the observation from earlier in vivo molecular imaging. 39 Together with the chimeric bone marrow transplantation in vivo, these studies highlight the importance of a macrophage phenotype switch regulated by COMP during atherosclerotic calcification.
We have previously reported that COMP inhibits medial VSMC calcification by direct antagonism of bone morphogenetic protein 2. 22 In this study, we further revealed a novel role of COMP in inhibiting atherosclerotic calcification by regulating a macrophage phenotypic switch. Interestingly, COMP deficiency in bone marrow of donor mice rather than in recipient mice confers lesion calcification, whereas VSMC-specific COMP-Tg displayed no effect on cartilaginous metaplasia, indicating that bone marrow-derived cells seem more important in intimal calcification. Our data also reinforce the idea that although intimal and medial calcification show some coincidence and overlap, they differ in terms of risk factors, topography, molecular cascades, and clinical consequences. On the other hand, our study revealed that intimal calcification is not paralleled with atherosclerotic lesion as evidenced that 7 The role of COMP in atherosclerosis was in line with previous observation. 40 The study reported that COMP deficiency increased the brachiocephalic lesions but had no effects on the carotid lesions by periadventitial cast injury of carotid artery in 14-week high fat-fed ApoE −/− mice. However, neither lesions in other atheroprone locations, including the aortic root and arch, nor the cellular origins of COMP were investigated in that study.
Our finding that the most severe intimal calcification was observed when COMP was absent from both vessel and bone marrow further raised the important issue of macrophage/ VSMC cross talk in atherosclerotic calcification. Previous studies have shown that macrophages were activated by oxidative low-density lipoprotein-stimulated calcifying vascular cell mineralization via cell-cell interaction and the production of soluble factors. 11 Other reports have indicated roles for activated macrophages in high-phosphate or β-glycerophosphate-stimulated VSMC calcification. 41, 42 Our study, however, used a coculture system with macrophages and VSMCs in the absence of stimulators. Even without high-phosphate stimulation, COMP −/− macrophages stimulated calcification of normal VSMCs. This effect was further aggravated when COMP was absent from both macrophages and VSMCs, indicating that these 2 cells have a synergistic effect in lesion calcification. It is well recognized that osteogenic factors released from macrophages can promote osteogenic process. 12 Conditioned medium from macrophages with elevated expression of Wnt10b, BMP-6, and SPHK1 (which catalyzes the phosphorylation of sphingosine to form S1P) could stimulate human mesenchymal stem cell migration and differentiation into the osteoblast lineage as evidenced by mineralized nodule formation in vitro, whereas conditioned medium containing the Wnt antagonist Dkk1, neutralizing antibodies against BMP-6, TNF-α, and IL-6, and an S1P antagonist blocked further osteoblast differentiation. 10 Here, we showed that COMP deficiency increased the expression of proinflammatory cytokines (such as IL-6 and by guest on November 18, 2017 http://circres.ahajournals.org/ Downloaded from TNF-α) and osteogenic factors (such as Wnt10b) in macrophages in vitro and in vivo and in turn stimulated VSMC calcification. Of interest, SMC COMP-Tg inhibited medial calcification in ex vivo aortic rings but had no effect on intimal calcification in ApoE −/− mice. The possible reason for this distinct function of VSMC-derived COMP may be because of the various cellular compositions in different calcification sites, as well as VSMC phenotypic switching. VSMCs constitute the major cell type of vascular media and mainly determine the fate of medial calcification. In contrast, intimal calcification involves complex cellular components. The macrophage percentage in atherosclerotic lesion is much greater than that of VSMCs (43.4%-62.7% versus 8.1%-9.3%). 43 More recent lineage tracing studies further revealed that a portion of macrophage-like cells within intimal plaques originated from VSMCs through dedifferentiating while losing contractile VSMC markers, and this switching directly promotes atherosclerosis. 44, 45 Thus, although our in vitro data indicated that both VSMCs and macrophage deficiency of COMP promoted VSMC calcification in coculture model, our chimeric mice model and SMC COMP-Tg data suggest that COMP deficiency in macrophages may play a more important role in lesional calcification than lacking of COMP in VSMCs.
Herein, we reported that COMP deficiency modulated macrophage phenotypes through integrin β3 in vitro and in vivo. Integrin β3 deficiency in macrophages has been reported to aggravate atherosclerotic lesions by enhancing the macrophage inflammatory phenotype, 33 which was consistent with the effects of COMP deficiency in macrophages. Overexpression of integrin β3 in COMP-deficient macrophages prevented the enhanced inflammation, reactive oxygen species production, and low-density lipoprotein uptake, whereas the atherogensis was also attenuated in ApoE −/− COMP −/− mice by injection of AAV2-integrin β3. Furthermore, integrin β3 deficiency in osteoclasts decreased their suppressive effect on osteogenesis and instead promoted osteosclerosis or osteopetrosis, 34 indicating that integrin β3 deficiency in macrophages contributed to osteogenesis. This was further emphasized by our data showing that overexpression of integrin β3 in COMP-deficient macrophages reversed the increases in Wnt10b expression and VSMC calcification, whereas blocking COMP-integrin β3 interaction by overexpression of β-tail domain in WT macorphage phenocopied the COMP −/− cells. We further confirmed in in vivo experiments that cartilaginous metaplasia was inhibited in ApoE −/− COMP −/− mice transduced with AAV2-integrin β3 but enhanced in ApoE −/− mice infected with AAV2-β-tail domain. Thus, these data highlight the importance of the COMP-integrin β3 axis in modulating macrophage phenotypes and atherosclerotic calcification. Besides integrin β3, whether other molecules also mediated COMP deficiencyaggravated atherosclerotic calcification needs further investigation. We previously reported that COMP is a natural inhibitor of thrombin and its deficiency in bone marrow accelerated hemostasis and thrombosis in mice, 46 indicating that bone marrow-derived COMP also inhibits hemostasis and thrombosis. To date, there is no report on the direct association between thrombin and atherosclerotic calcification, but thrombin was reported to cleave the anticalcific factor osteopontin. 47 Thus, whether the inhibitory effect of COMP on thrombin is involved in atherosclerotic calcification may need further studies. We also measured COMP in mice plasma after bone marrow transplantation by ELISA (Online Table III In conclusion, COMP deficiency drove macrophages toward an atherogenic and osteogenic phenotype to promote atherosclerotic calcification via suppressing integrin β3. Thus, the application of the extracellular matrix protein COMP to modulate macrophage phenotypes may be a potential therapeutic method for ameliorating atherogenesis, atherosclerotic calcification, and plaque rupture.
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What Is Known?
• Atherosclerotic calcification is highly correlated with atherosclerotic plaque burden.
• Cartilage oligomeric matrix protein (COMP) plays a protective role in vascular smooth muscle cell calcification.
What New Information Does This Article Contribute?
• COMP deficiency drives the development of atherosclerotic calcification.
• COMP deficiency primes lesional macrophages toward an atherogenic and osteogenic but not anti-inflammatory or osteoclast phenotype.
• COMP-integrin β3 interaction in macrophages but not in vascular smooth muscle cells plays an essential role in atherosclerotic calcification.
The role of macrophages in the pathogenesis of atherosclerotic calcification is poorly understood. 
Supplemental Material
Methods
Materials
Antibodies against integrin β1 and β3 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibody against GAPDH was obtained from Cell Signaling Technology (Boston, MA, USA). The antibody against COMP was obtained from Abcam (Cambridge, UK). Antibody against Wnt10b was purchased from ABGENT (San Diego, CA, USA). Antibodies applied for flow cytometry were purchased from BioLegend (San Diego, CA, USA). Reconstituted mouse IL-4 and IFNγ were purchased from PeproTech (Rocky Hill, NJ, USA). Thioglycollate was purchased from BD Biosciences (San Diego, CA, USA). DiI-ac-LDL was obtained from Life Technologies (Grand Island, NY, USA). IRDye-conjugated secondary antibodies for western blotting were purchased from Rockland, Inc. (Gilbertsville, PA, USA). Other reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless specified.
Animals
All animal studies followed the guidelines of the Animal Care and Use Committee of Peking University. COMP -/-mice in the C57BL/6 background strain were kindly provided by Professor Oldberg 
Measurement of Plasma Lipids and COMP
Mice were euthanized using CO2, and blood was collected by cardiac puncture with EDTA as an anticoagulant. Blood cells were analyzed by flow cytometry. Plasma was isolated by centrifuging blood at 3,000 g for 20 min. Total plasma cholesterol levels and triglyceride were assayed with kits from Zhong Sheng Bio-technology (Beijing, China). COMP in plasma were measured via ELISA kit following the product user's manual (Immunodiagnotis systems, Bolden Business Park, United Kingdom).
Analysis of Atherosclerotic Plaques and Calcification
Mice were euthanized and lesions in the whole aortic tree and in frozen cross-sections of the aortic root, arch and innominate artery were analyzed separately as described in the previous studies.
2, 3 The whole aorta was exposed and the perivascular tissues were removed in situ. Subsequently, the aorta was completely isolated and further incisions were made following the ventral side of the aorta, the inner curvature of the aorta and the outer curvature of the arch. Then, the flattened aorta was fixed on a black wax surface in a dissecting pan for Oil Red O staining. For further morphometric analysis of lesions, cross-sections of various artery parts including aortic root, arch and innominate artery were prepared individually. Moving up from the base of heart, aortic root region begins at the first appearance of the valve cups dividing the lumen into three distinct regions, and ends when the valve cups no longer divide the lumen and the wall appears more rounded and distinct. Aortic arch region for lesion analysis starts at the branch point of innominate artery then moving backwards to the aortic root. Innominate artery region begins at its origin on the outer curve of aortic arch and ends at its first branch which is divided as right common carotid artery and right subclavian artery. Every three continuous 7 m thick sections were made on separate slides without interval for aortic root and with 70 m intervals for aortic arch and innominate artery respectively with a cryostat through these arterial parts. For each mouse, three sets of ten intervals sections were applied for Oil Red O, von Kossa and Movat pentachrome stainings. Cross-sections were with Oil Red O to allow assessment of atherosclerotic plaques, and images were captured by microscopy. 4 Von Kossa staining was performed to detect atherosclerotic calcification.
2, 5
The frozen sections were incubated with 1% AgNO3 under ultraviolet light for 20-60 min depending on the light intensity. Then, un-reacted silver was removed by incubation with 5% Na2S2O3 for 5 min. Before mounting, sections were counterstained with DAPI to identify nuclei. Stained sections were imaged using an Olympus microscopy system and evaluated blindly by two independent investigators. The total lesion area and calcification area were quantified as the percentage of plaque or calcification area to artery lumen area in each section individually, and the mean percentage of ten sections was recorded as the lesion data for each mouse.
Movat pentachrome staining kit (Leagene Biotechnology, Beijing, China) were applied on the cross-sections of innominate artery for assessing the atherosclerotic necrotic core and cartilaginous metaplasia. Two independent investigators who were blinded to the study protocol evaluated each section. In atherosclerotic lesions, necrotic core indicated as the non-cellular area without significant staining. Cartilaginous metaplasia was defined as a collagen-(yellow) and proteoglycan-(blue) rich extracellular matrix embedded with chondrocyte-like cells visualized as relatively large amount of clear cytoplasm surrounded by a lacunae. 6, 7 Both of necrotic core and cartilaginous metaplasia were quantified as the mean percentages of their area to the respective plaque area from ten sections for each mouse.
Bone Marrow Transplantation
Bone marrow transplantation was performed as described in previous reports with minor modifications. 8, 9 Mice were exposed to γ-irradiation from 60 Co (Department of Applied Chemistry, Peking University) followed by the injection of bone marrow cells (5×10 6 cells/mice) via the tail vein.
To confirm the lethal exposure dose, mice that did not receive bone marrow injections were used as controls. ApoE -/-mice (8 weeks old) were exposed to 9 Gy of γ-irradiation. Control mice died 2 weeks post-irradiation, whereas all engrafted mice survived. However, all ApoE -/-COMP -/-mice that received bone marrow cells died following 9 Gy of irradiation. To avoid high mortality from engraftment, 4 Gy of γ-irradiation was applied twice at a 4-hour interval 10 . ApoE -/-COMP -/-mice exposed to 2×4 Gy survived when injection with bone marrow cells, whereas all control mice died within 2 weeks. Nevertheless, 1/4 of the ApoE -/-control mice survived after 2×4 Gy exposure. Thus, 9 Gy of irradiation was used as the lethal dose for ApoE -/-mice, and 2×4 Gy was used for ApoE . We evaluated the degree of engraftment after these two exposure doses as approximately 70-93% following bone marrow reconstitution. 11 At 6 weeks post-transplantation, blood from chimeric mice was collected for genotyping and routine blood tests to detect bone marrow reconstitution. Then, the reconstituted mice were fed with Western-type diet (D12108, 40 kcal% fat and 1.25% cholesterol, Research Diets Inc., New Brunswick, NJ, USA) for 16 weeks, and atherosclerotic plaques and calcification were assessed as described above.
Cell Isolation and Culture
Mouse peritoneal macrophages were isolated from thioglycollate-injected mice as described in a previous study. 12 Briefly, each wild type (WT) or COMP -/-mouse was intraperitoneally injected with 5 mL of 2.9% thioglycollate. Four days later, the cells were perfused from the peritoneal cavity and cultured with DMEM (Life Technologies, Grand Island, NY, USA) including 10% fetal bovine serum (FBS) (Life Technologies, Grand Island, NY, USA). Bone marrow cells were isolated and differentiated into bone marrow-derived macrophages (BMDMs) in complete DMEM containing 30% conditioned medium from L929 cells. 13 Primary aortic VSMCs were isolated from the aortas of Sprague-Dawley rats (150-180 g) and cultured with DMEM including 10% FBS as described previously 14 , and cells at passage 3-4 were applied for in vitro experiments. Primary bovine aortic endothelial cells (BAECs) were generously donated by Dr. Jing Zhou from Peking University. BAECs were maintained and subcultured in DMEM including 10% FBS as described previously 15 .
Aortic Digestion
Aortas, including thoracic (ascending, arch and descending aorta) and abdominal segments, were dissected from ApoE -/-or ApoE -/-COMP -/-mice, and the connective and fat tissues surrounding vessels were removed completely. Aortic tissues were digested into single cells using 1 mL aortic dissociation enzyme solution as described previously. 16 The digested single cell solution was used for flow cytometry or fluorescence activated cell sorting.
Flow Cytometric Analysis and Cell Sorting
Mouse bone marrow cells were labeled using FITC-conjugated anti-mouse CD45, PE-conjugated anti-mouse Gr-1 and APC-conjugated anti-mouse CD11b antibodies to identify myeloid cells. Blood cells were analyzed using FITC anti-CD45 and APC anti-CD11b together with PE-conjugated antimouse Ly6C or Ly6G antibodies to identify monocytes or neutrophils, respectively, following the disruption of red blood cells using RBC lysis buffer (Tiangen Biotech Inc., Beijing, China). Co-labeling with PE anti-F4/80 and APC anti-CD11b antibodies was used to distinguish peritoneal macrophages from peritoneal cells isolated from mice without thioglycollate elicitation. For bone marrow-derived macrophages, first, PE anti-F4/80 was applied to identify the differentiated macrophages, and then APC-conjugated anti-mouse CD86 and CD206 antibodies were used to measure the cell-surface protein expression. Macrophages in single-cell suspensions derived from mouse aortas were co-labeled with PE anti-F4/80 and APC anti-CD11b antibodies, and then the cell surface proteins CD86, CD206, and integrin β3 were detected using the corresponding fluorescence-labeled antibodies. To measure Wnt10b in aortic macrophages, cells were permeabilized using BD Cytofix/Cytoperm Fixation/Permeabilization Kit (BD Biosciences, San Diego, CA, USA) following co-labeling with PE anti-F4/80 and APC antiCD11b antibodies. Permeabilized cells were incubated with rabbit anti-Wnt10b and FITC-labeled antirabbit IgG antibodies to measure Wnt10b in aortic macrophages. Generally collected cells (1×10 5 /tube) were incubated for 30 min on ice with either the aforementioned antibodies or their respective isotype controls. After the unbound antibodies were washed out, labeled cells were examined using a BD FACS Calibur system (BD Biosciences, San Diego, CA, USA). For analysis, 10,000 cell counts per tube were collected and analyzed using Cell Quest (BD Biosciences, San Diego, CA, USA) or FlowJo (Tree Star Inc., Ashland, OR, USA). For sorting, single-cell suspensions from one atherosclerotic mouse were colabeled with FITC anti-CD45, PE anti-F4/80 and APC anti-CD11b antibodies, and the triply positive cells were sorted as lesional macrophages by BD FACS Aria II SORP (BD Biosciences, San Diego, CA, USA) for further RNA isolation and real-time PCR gene detection.
Transmigration Assay
Migration assays were performed using 8.0 μm transwells (BD Biosciences, San Diego, CA, USA) as previously described with minor modifications. 12 Briefly, bovine aortic endothelial cells (BAECs)
were grown to confluence on the upper chamber overnight. Mouse mononuclear cells isolated from peripheral blood of WT and COMP -/-mice were stained with CM-DiI dye (Life Technologies, Grand
Island, NY, USA) for 20 min. Stained cells were seeded at density of 10 4 per chamber on the upper chamber and coincubated with BAECs and MCP-1 (100 ng/ml) was added to the lower chamber. In 4 hours, cells migrating to the lower chamber were collected and determined using a microplate reader (ThermoFisher Scientific, Grand Island, NY, USA) with excitation at 553 nm and detection at 570 nm.
Gene-expression Microarray
Peritoneal macrophages were isolated from WT and COMP -/-mice injected with thioglycollate, and mRNA was isolated from 2×10 6 cells extracted from 6 mice per sample using Trizol. RNA quantity and quality were measured using NanoDrop ND-1000, whereas RNA integrity was assessed using standard denaturing agarose gel electrophoresis. Briefly, total RNA from each sample was used for labeling and array hybridization using the following steps: 1) Reverse transcription using Invitrogen SuperScript ds-cDNA synthesis kit. 2) dscDNA labeling with NimbleGen one-color DNA labeling kit. 3) Array hybridization using the NimbleGen Hybridization System, followed by washing with the NimbleGen wash buffer kit. 4) Array scanning using the Axon GenePix 4000B microarray scanner (Molecular Devices Corporation). Scanned images (TIFFs) were then imported into NimbleScan software (Version 2.5) for grid alignment and expression data analysis. Expression data were normalized using quantile normalization and the Robust Multichip Average (RMA) algorithm included in the NimbleScan software. All gene level files were imported into Agilent GeneSpring GX software (Version 11.5.1) for further analysis. Genes that were expressed at significantly different levels between the two groups were identified through Volcano Plot filtering. Differentially expressed genes were identified through Fold Change filtering (>2.0; <0.5). Pathway Analysis (KEGG) and GO analysis were used to analyze the functions of the differentially expressed genes. Microarray data are available at www.ncbi.nlm.nih.gov/geo/, accession numbers GSE73944.
Aortic Ring Organ Calcification
The aortas were removed from smooth muscle cell specific COMP transgenic (SMC COMP-Tg) mice or littermate wild type C57/BL6 mice. After the adventitia and endothelium were carefully removed, the vessels were cut into 2-to 3-mm rings and placed in a high-phosphate medium (10% FBS DMEM with 3.8 mM inorganic phosphate) or regular DMEM containing 10% FBS at 37 o C in 5% CO2
for 7 consecutive days; the medium was changed every 2 days. Seven days later, the aortic rings were harvested to investigate the level of calcium deposition. The viability of the aortic rings was monitored by a methylthiazoletertrazolium (MTT) assay.
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